Fei-Ting Hsu

18PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imagingHaematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 01, 2025
Imipramine Inhibits Osteosarcoma Invasion via Src Inactivation and Caspase-Dependent Apoptosis.

Yu-Chang Liu, Chi-Jung Fang, Li-Cho Hsu

|Aug 20, 2025
Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targeting the EGFR/NF-κB Pathway and Immune Modulation.

Yu-Chang Liu, Chih-Ying Liao, Fei-Ting Hsu

|Aug 14, 2025
Galactosylated iron oxide nanoplatforms for targeted imaging and ferroptosis-enhanced glioblastoma therapy <i>via</i> immune modulation.

Yu-Cheng Chin, Ying-Tzu Chen, Yi-Chun Chiu

|Oct 09, 2024
Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer.

Fei-Ting Hsu, Ying-Tzu Chen, Yu-Cheng Chin

|May 13, 2023
Inactivation of EGFR/ERK/NF-κB signalling associates with radiosensitizing effect of 18β-glycyrrhetinic acid on progression of hepatocellular carcinoma.

Yu-Chang Liu, Cheng Hsun Lin, Kuan-Tin Chen

|Feb 02, 2023
Amentoflavone induces caspase-dependent/-independent apoptosis and dysregulates cyclin-dependent kinase-mediated cell cycle in colorectal cancer in vitro and in vivo.

Cheng-Hsun Lin, Kuang-Hsuan Lin, Hsiang-Ju Ku

Pageof 3

Frequent Collaborators

5 joint publications

Jing-Gung Chung

4 joint publications

Yu-Chang Liu

2 joint publications

Chih-Chia Huang

2 joint publications

Yu-Cheng Chin